According to I-Mab Biopharma's latest financial reports the company's current earnings are โฌ36.36 Million. In 2022 the company made an earning of -โฌ0.35 Billion, an increase over its 2021 earnings that were of -โฌ0.35 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.